Call Start: 17:00 January 1, 0000 5:41 PM ET
Aurora Cannabis Inc. (NASDAQ:ACB)
Q2 2023 Earnings Conference Call
February 09, 2023 05:00 PM ET
Company Participants
Ananth Krishnan - VP, Strategic Finance
Miguel Martin - CEO
Glen Ibbott - CFO
Conference Call Participants
Vivien Azer - Cowen
Michael Lavery - Piper Sandler
Andrew Carter - Stifel
Matthew Baker - Cantor Fitzgerald
Frederico Gomes - ATB Capital
John Zamparo - CIBC
Matt Bottomley - Canaccord Genuity
Operator
Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce to you, Ananth Krishnan, Vice President, Corporate Development and Investor Relations. Thank you, Ananth. You may begin.
Ananth Krishnan
Thank you, John, and good afternoon, everyone. We appreciate you joining us today. With me are, CEO, Miguel Martin; and CFO, Glen Ibbott.
After the market closed, Aurora issued a news release announcing our fiscal 2023 second quarter financial results. This news release, accompanying financial statements and MD&A are available on our IR website and can also be accessed via SEDAR and EDGAR. In addition, you will find a supplemental information deck on our IR website.
Listeners are reminded that certain matters discussed on today’s conference call could constitute forward-looking statements that are subject to risks and uncertainties related to our future financial or business performance. Actual results could differ materially from those anticipated in these forward-looking statements. The risk factors that may affect actual results are detailed in our Annual Information Form and other periodic filings and registration statements. These documents may similarly be accessed via SEDAR and EDGAR.
Following prepared remarks by Miguel and Glen, we will conduct a question-and-answer session with our analysts. We ask you to limit yourselves to one question and then get back in the queue for follow-up.
With that, I will turn the call over to Miguel. Miguel, please go ahead.
Miguel Martin
Thank you, Ananth. First and foremost, we are very proud to have achieved what we set out to do several quarters ago, namely, reaching our objective a positive adjusted EBITDA by the end of the 2022 calendar year. We are confident that we can deliver positive adjusted EBITDA on annualized basis going forward. Although there may be some quarter-to-quarter variability due to the dynamic nature of the cannabis industry, and the seasonality we previously talked about at our Bevo business.